Anthony-jake Demetris
#110,479
Most Influential Person Now
Anthony-jake Demetris's AcademicInfluence.com Rankings
Anthony-jake Demetrisphilosophy Degrees
Philosophy
#4621
World Rank
#7209
Historical Rank
Logic
#2040
World Rank
#2937
Historical Rank
Anthony-jake Demetrisbiology Degrees
Biology
#6077
World Rank
#8710
Historical Rank
Pathology
#71
World Rank
#155
Historical Rank
Download Badge
Philosophy Biology
Why Is Anthony-jake Demetris Influential?
(Suggest an Edit or Addition)Anthony-jake Demetris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Banff 97 working classification of renal allograft pathology. (1999) (3030)
- Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. (2005) (1303)
- Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions (2014) (1195)
- Banff schema for grading liver allograft rejection: An international consensus document (1997) (1152)
- Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection (2003) (1033)
- Production of α1,3-Galactosyltransferase-Deficient Pigs (2002) (947)
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells (2006) (896)
- Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. (1997) (875)
- Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
- The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. (1988) (705)
- Hepatic resection versus transplantation for hepatocellular carcinoma. (1991) (621)
- Production of alpha 1,3-galactosyltransferase-deficient pigs. (2003) (531)
- Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease (1991) (520)
- Human polyoma virus-associated interstitial nephritis in the allograft kidney. (1999) (505)
- Tolerogenic immunosuppression for organ transplantation (2003) (493)
- Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center (2000) (489)
- Murine liver allograft transplantation: Tolerance and donor cell chimerism (1994) (469)
- Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome (1998) (456)
- Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection (2000) (452)
- Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. (2007) (426)
- Weaning of immunosuppression in liver transplant recipients. (1997) (413)
- Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis (2005) (345)
- CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION (1993) (337)
- Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome (2005) (337)
- 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection (2016) (330)
- Liver biopsy interpretation for causes of late liver allograft dysfunction (2006) (313)
- A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation (2016) (300)
- Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. (2012) (297)
- The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection (2020) (283)
- Acute antibody-mediated rejection of cardiac transplants. (2006) (276)
- Mitosis and apoptosis in the liver of interleukin‐6–deficient mice after partial hepatectomy (1999) (269)
- HUMAN ISLET ISOLATION AND ALLOTRANSPLANTATION IN 22 CONSECUTIVE CASES 1, 2 (1992) (257)
- Liver Transplantation Using Donation After Cardiac Death Donors: Long‐Term Follow‐Up from a Single Center (2009) (252)
- The lost chord: microchimerism and allograft survival. (1996) (246)
- Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies (1989) (240)
- IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival (2011) (237)
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506 (1990) (224)
- FK 506 for human liver, kidney, and pancreas transplantation (1989) (223)
- Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. (1997) (221)
- Nephropathy due to polyomavirus type BK. (2000) (205)
- Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. (1988) (204)
- Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome (2006) (200)
- MELD and prediction of post–liver transplantation survival (2006) (199)
- Microchimerism, dendritic cell progenitors and transplantation tolerance (1995) (188)
- Upper-Extremity Transplantation Using a Cell-Based Protocol to Minimize Immunosuppression (2013) (184)
- Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. (1992) (181)
- Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report (2018) (180)
- Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia (1992) (177)
- Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. (2005) (176)
- Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. (1997) (172)
- Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. (1997) (169)
- A schema for histologic grading of small intestine allograft acute rejection (2003) (166)
- Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. (2001) (163)
- Liver transplantation for severe intrahepatic noncirrhotic portal hypertension (2005) (160)
- Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth (2004) (159)
- Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C (2006) (157)
- A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factors (1989) (154)
- Assessment of five-year experience with abdominal organ cluster transplantation. (1995) (153)
- Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. (1993) (152)
- Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin‐6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro (1994) (150)
- Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients (1995) (150)
- CADAVERIC SMALL BOWEL AND SMALL BOWEL‐LIVER TRANSPLANTATION IN HUMANS 1,2 (1992) (149)
- Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. (2000) (147)
- Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus (2004) (145)
- The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. (2004) (139)
- Terminology for hepatic allograft rejection (1995) (139)
- FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1 (1994) (139)
- Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. (1996) (139)
- Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. (1997) (139)
- A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C (2002) (136)
- Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury (1990) (134)
- Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. (1995) (133)
- FK 506 in clinical kidney transplantation. (1991) (131)
- DISEASE RECURRENCE AND REJECTION FOLLOWING LIVER TRANSPLANTATION FOR AUTOIMMUNE CHRONIC ACTIVE LIVER DISEASE (1992) (130)
- Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. (1996) (126)
- Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence‐free survival (2003) (124)
- Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. (1989) (123)
- Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. (1990) (122)
- SPLIT TOLERANCE INDUCED BY ORTHOTOPIC LIVER TRANSPLANTATION IN MICE1 (1994) (121)
- Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. (2000) (121)
- Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. (1986) (119)
- THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 (1992) (118)
- Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. (1996) (118)
- Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. (1989) (115)
- A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies (1992) (114)
- WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS (1995) (114)
- Liver Preservation With Machine Perfusion and a Newly Developed Cell‐Free Oxygen Carrier Solution Under Subnormothermic Conditions (2015) (110)
- CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTS (1992) (110)
- A prospective randomized trial of FK506-based immunosuppression after renal transplantation. (1995) (109)
- Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance (2009) (109)
- The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. (2000) (109)
- SMALL INTESTINAL TRANSPLANTATION IN HUMANS WITH OR WITHOUT THE COLON1,2 (1994) (108)
- Liver Transplantation, A 31 Year Perspective (1990) (107)
- Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. (1997) (107)
- Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. (2005) (107)
- Tacrolimus rescue therapy for renal allograft rejection--five-year experience. (1997) (105)
- Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. (2008) (104)
- Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance. (1998) (104)
- The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. (1996) (104)
- Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. (2018) (103)
- Regulatory Dendritic Cell Infusion Prolongs Kidney Allograft Survival in Nonhuman Primates (2013) (103)
- Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. (1991) (103)
- Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent Weaning (2003) (102)
- Liver allograft rejection: an overview of morphologic findings. (1990) (102)
- A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C (2002) (101)
- Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis (2002) (100)
- Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. (2001) (99)
- Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin (2001) (99)
- THE INFLUENCE OF HLA MATCHING ON CYTOMEGALOVIRUS HEPATITIS AND CHRONIC REJECTION AFTER LIVER TRANSPLANTATION (1993) (98)
- Frequent achievement of a drug-free state after orthotopic liver transplantation. (1993) (96)
- Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells (1992) (95)
- Interleukin‐6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type i ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium (1998) (95)
- Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. (1996) (94)
- Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. (1992) (94)
- Antibody‐mediated rejection as a contributor to previously unexplained early liver allograft loss (2014) (93)
- Transplantation for primary biliary cirrhosis. (1988) (93)
- LIVER TRANSPLANTATION (First of Two Parts) (1989) (92)
- Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. (2008) (90)
- Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. (1992) (90)
- Tumor necrosis factor‐α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia (1994) (89)
- Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. (1989) (88)
- Proposed Diagnostic Criteria for Chronic Antibody‐Mediated Rejection in Liver Allografts (2016) (87)
- Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. (1994) (86)
- Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis (2004) (85)
- Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. (1991) (85)
- Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. (1999) (85)
- Long-term survival after liver transplantation in 4000 consecutive patients at a single center (2000) (85)
- Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. (1990) (84)
- Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database (2008) (84)
- Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. (1997) (84)
- INDUCTION OF DR/IA ANTIGENS IN HUMAN LIVER ALLOGRAFTS: AN IMMUNOCYTOCHEMICAL AND CLINICOPATHOLOGIC ANALYSIS OF TWENTY FAILED GRAFTS (1985) (83)
- Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients (1991) (83)
- Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation (1994) (82)
- Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development (2008) (81)
- Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. (1993) (81)
- Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice. (2015) (80)
- Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow‐up of 6 years (2001) (80)
- Histologic Graft Assessment After Clinical Islet Transplantation (2009) (79)
- Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. (2001) (78)
- Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver Transplantation (2008) (78)
- Outcomes of immunosuppression minimization and withdrawal early after liver transplantation (2018) (78)
- Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B‐HOT) gene panel and open source multicenter validation (2020) (78)
- Early trials with FK 506 as primary treatment in liver transplantation. (1990) (77)
- Caroli's disease and orthotopic liver transplantation (2006) (76)
- Epstein‐Barr Virus—Associated Syndromes in Immunosuppressed Liver Transplant Recipients: Clinical Profile and Recognition on Routine Allograft Biopsy (1990) (76)
- Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation (2003) (73)
- Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction (2012) (73)
- 85-kDa Cytosolic Phospholipase A2 Mediates Peroxisome Proliferator-activated Receptor γ Activation in Human Lung Epithelial Cells* (2002) (73)
- Pathologic analysis of liver transplantation for primary biliary cirrhosis (1988) (72)
- Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis? (2008) (72)
- Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation. (2013) (72)
- Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema. (1997) (72)
- Five‐year histological and serological follow‐up of operationally tolerant pediatric liver transplant recipients enrolled in WISP‐R (2017) (72)
- Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. (1993) (70)
- Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. (1994) (70)
- GRAFT‐VERSUS‐HOST DISEASE AFTER BROWN NORWAY‐TO‐LEWIS AND LEWIS‐TO‐BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK506 (1993) (70)
- Acute liver allograft antibody‐mediated rejection: An inter‐institutional study of significant histopathological features (2014) (70)
- Cytokine Mrna Profiles In Mouse Orthotopic Liver Transplantation Graft Rejectionis Associasted With Augmented Th1 Function (1995) (69)
- Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (2012) (69)
- Functional Immune Anatomy of the Liver—As an Allograft (2016) (68)
- Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. (2000) (68)
- Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic Cells (2011) (68)
- Intrahepatic biliary strictures after liver transplantation. (1994) (67)
- Evolution of hepatitis C virus in liver allografts (2009) (66)
- Histologic Abnormalities are Common in Protocol Liver Allograft Biopsies From Patients With Normal Liver Function Tests (2008) (65)
- Occurrence of cytomegalovirus hepatitis in liver transplant patients (1988) (65)
- Orthotopic liver transplantation in dogs receiving FK-506. (1987) (65)
- Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. (1997) (64)
- Transforming Growth Factor-β (TGF-β) Activates Cytosolic Phospholipase A2α (cPLA2α)-mediated Prostaglandin E2 (PGE)2/EP1 and Peroxisome Proliferator-activated Receptor-γ (PPAR-γ)/Smad Signaling Pathways in Human Liver Cancer Cells (2004) (64)
- Liver Transplantation in Precirrhotic Biliary Tract Disease: Portal Hypertension is Frequently Associated With Nodular Regenerative Hyperplasia and Obliterative Portal Venopathy (2006) (64)
- Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. (2001) (63)
- Lymphoma resembling hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient (1993) (63)
- Liver transplants contribute to their own success (1996) (63)
- Five Cases of Fulminant Hepatitis Due to Herpes Simplex Virus in Adults (2002) (63)
- PPARγ ligands inhibit cholangiocarcinoma cell growth through p53‐dependent GADD45 and p21WAF1/Cip1 pathway (2003) (63)
- Central venulitis in the allograft liver: a clinicopathologic study. (1997) (62)
- Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema. (1999) (62)
- Gut‐derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin‐6/signal transducer and activator of transcription 3 activity (2007) (62)
- Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression (1992) (61)
- IMMUNOMODULATION FOR INTESTINAL TRANSPLANTATION BY ALLOGRAFT IRRADIATION, ADJUNCT DONOR BONE MARROW INFUSION, OR BOTH1 (2000) (61)
- Immunopathology of cardiac transplant rejection (1995) (60)
- Hepatic epithelioid hemangioendothelioma: biological questions based on pattern of recurrence in an allograft and tumor immunophenotype. (1997) (60)
- Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant (2022) (60)
- Re‐examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? (2012) (60)
- Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. (1996) (59)
- Tacrolimus (FK506)-Associated Renal Pathology. (1997) (59)
- Lessons of organ-induced tolerance learned from historical clinical experience. (2004) (59)
- Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts. (1995) (58)
- Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small‐for‐size syndrome (2009) (58)
- Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. (1994) (58)
- Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation (1992) (56)
- Chromosomal breakpoints in cholangiocarcinoma cell lines (1990) (56)
- Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. (1994) (56)
- Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium. (1997) (55)
- Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance (1995) (55)
- Posttransplant adenoviral enteropathy in patients with small bowel transplantation. (2008) (54)
- Exogenous IL‐6 Inhibits Acute Inflammatory Responses and Prevents Ischemia/Reperfusion Injury after Intestinal Transplantation (2004) (54)
- Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study (2001) (54)
- Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics (2012) (54)
- One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. (1991) (54)
- Chronic Rejection of Small Bowel Grafts: Pediatric and Adult Study of Risk Factors and Morphologic Progression (2003) (54)
- NK Cells Delay Allograft Rejection in Lymphopenic Hosts by Downregulating the Homeostatic Proliferation of CD8+ T Cells (2010) (54)
- The lost chord: Microchimerism (1996) (54)
- Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation (1998) (54)
- Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective (2009) (53)
- The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers (2008) (53)
- Liver transplantation: a 31-year perspective. Part I. (1990) (53)
- S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? (1989) (53)
- Role of Splenectomy in Human Liver Transplantation Under Modern-Day Immunosuppression (1998) (53)
- Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. (1993) (52)
- Clinical intestinal transplantation: a decade of a single center experience (2001) (52)
- Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. (1998) (52)
- Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. (1994) (51)
- Immunosuppression for liver transplantation in HCV‐infected patients: Mechanism‐based principles (2005) (50)
- Real-time monitoring of acute liver-allograft rejection using the Banff schema. (2002) (50)
- Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis (1992) (50)
- Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease. (1996) (50)
- Langerhans cells are not required for graft-versus-host disease. (2011) (49)
- Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1 (2002) (49)
- PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN RATS USING FK506 (1991) (49)
- Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. (2006) (48)
- Real-time monitoring of acute liver-allograft rejection using the Banff schema1 (2002) (48)
- Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ‘two-hit hypothesis’ (2016) (46)
- Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. (1998) (46)
- Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation (2005) (46)
- The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. (1991) (46)
- Lipid peroxidation of liver microsome membranes induced by choline-deficient diets and its relationship to the diet-induced promotion of the induction of gamma-glutamyltranspeptidase-positive foci. (1985) (45)
- Pathologic observations in human allograft recipients treated with FK 506. (1990) (45)
- Roles of dendritic cells in murine hepatic warm and liver transplantation‐induced cold ischemia/reperfusion injury (2013) (45)
- ABO-compatible liver allograft antibody-mediated rejection: an update (2015) (45)
- Estrogen stimulates female biliary epithelial cell interleukin‐6 expression in mice and humans (2010) (44)
- 85-kDa cPLA2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells (2002) (44)
- A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. (1995) (44)
- Idiopathic posttransplantation hepatitis? (2007) (43)
- Long-Term Effects of Alemtuzumab on Regulatory and Memory T-Cell Subsets in Kidney Transplantation (2012) (43)
- CD24hiCD38hi and CD24hiCD27+ Human Regulatory B Cells Display Common and Distinct Functional Characteristics (2019) (43)
- PARTICIPATION OF DENDRITIC CELLS IN VASCULAR LESIONS OF CHRONIC REJECTION OF HUMAN ALLOGRAFTS (1988) (42)
- A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. (2011) (42)
- Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. (2011) (42)
- Minimal Evidence of Transdifferentiation from Recipient Bone Marrow to Parenchymal Cells in Regenerating and Long‐Surviving Human Allografts (2003) (41)
- Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. (2000) (41)
- Multiphoton Intravital Microscopy of the Transplanted Mouse Kidney (2011) (41)
- Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. (1995) (40)
- Regulation and function of trefoil factor family 3 expression in the biliary tree. (2004) (40)
- A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. (2004) (40)
- Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection (1991) (39)
- Use of OKT3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (1987) (39)
- Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. (1998) (38)
- Liver transplant rejection: angiographic findings in 35 patients. (1987) (38)
- The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro. (2000) (38)
- A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. (1994) (38)
- Transplantation Tolerance, Microchimerism, and the Two-Way Paradigm (1998) (38)
- Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders (1999) (38)
- Transplantation Milestones Viewed With One- and Two-Way Paradigms of Tolerance (1995) (38)
- Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation (2011) (38)
- Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus (2019) (38)
- Intrahepatic bile duct strictures after human orthotopic liver transplantation (1988) (37)
- Central venulitis in liver allografts: Considerations of differential diagnosis (2001) (37)
- Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. (2008) (37)
- Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management (2020) (37)
- Pathologist's perspective on liver needle biopsy size? (2003) (37)
- Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. (1997) (36)
- Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. (2001) (36)
- Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts (2017) (36)
- Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. (2002) (36)
- Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. (1991) (34)
- Procurement of liver allografts from non-heart beating donors. (1990) (34)
- Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. (1989) (34)
- The influence of donor and recipient strains in isolated small bowel transplantation in rats. (1994) (34)
- Adenovirus hepatitis in the adult allograft liver. (1997) (34)
- Wound Healing in the Biliary Tree of Liver Allografts (2006) (34)
- Evidence for heat shock protein immunity in a rat cardiac allograft model of chronic rejection. (1999) (34)
- Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. (1991) (33)
- Transmission of fatal herpes simplex infection through renal transplantation. (1988) (33)
- Tissue biopsy monitoring of operational tolerance in liver allograft recipients (2013) (33)
- Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. (1991) (32)
- Histopathologic Characteristics of Human Intestine Allograft Acute Rejection in Patients Pretreated with Thymoglobulin or Alemtuzumab (2006) (32)
- Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection (2006) (32)
- The Role of Passenger Leukocytes in Rejection and “Tolerance” after Solid Organ Transplantation: A Potential Explanation of a Paradox (1994) (32)
- Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. (1991) (32)
- Donor and recipient leukocytes in organ allografts of recipients with variable donor‐specific tolerance: With particular reference to chronic rejection (2000) (32)
- FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. (1993) (31)
- CASE REPORT: Azithromycin-Induced Intrahepatic Cholestasis (2002) (31)
- INHIBITION OF FREE RADICAL GENERATION AND IMPROVED SURVIVAL BY PROTECTION OF THE HEPATIC MICROVASCULAR ENDOTHELIUM BY TARGETED ERYTHROCYTES IN ORTHOTOPIC RAT LIVER TRANSPLANTATION (1990) (31)
- Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice (2000) (31)
- Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. (1993) (31)
- Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. (1992) (30)
- Modulation of Stat3 Activation by the Cytosolic Phospholipase A2α and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway* (2006) (30)
- SEQUENTIAL ANALYSES OF THE DEVELOPMENT OF LYMPHOPROLIFERATIVE DISORDERS IN RATS RECEIVING CYCLOSPORINE (1984) (30)
- IRF-1 Promotes Liver Transplant Ischemia/Reperfusion Injury via Hepatocyte IL-15/IL-15Rα Production (2015) (30)
- DE NOVO MALIGNANCIES AFTER INTESTINAL AND MULTIVISCERAL TRANSPLANTATION (2004) (30)
- A new liver perfusion and preservation system for transplantation research in large animals. (1990) (29)
- SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity (2012) (29)
- Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. (1993) (29)
- Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. (1998) (29)
- Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation (2008) (29)
- Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection (2016) (29)
- PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. (2003) (29)
- A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. (1998) (28)
- Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. (1997) (28)
- Preformed lymphocytotoxic antibodies: The effects of class, titer and specificity on liver vs. heart allografts (1992) (28)
- Graft versus host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506 (1993) (27)
- Chimerism after organ transplantation (1997) (27)
- Liver transplantation: a 31-year perspective. Part II. (1990) (27)
- Antibody deposition in liver allografts with chronic rejection. (1987) (27)
- Tacrolimus in renal transplantation. (1996) (27)
- Neurilemmoma (Schwannoma) of the Facial Nerve Presenting as a Parotid Mass (1993) (27)
- Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. (1989) (26)
- Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications. (2018) (26)
- Recipient B cells are not required for graft-versus-host disease induction. (2010) (26)
- DONOR SPECIES COMPLEMENT AFTER LIVER XENOTRANSPLANTATION: THE MECHANISM OF PROTECTION FROM HYPERACUTE REJECTION1,2 (1994) (26)
- Banff Digital Pathology Working Group: Going digital in transplant pathology (2020) (26)
- Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. (1999) (26)
- FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. (1991) (26)
- Postinfantile giant cell hepatitis associated with anti-M2 mitochondrial antibodies. (1994) (25)
- Liver transplantation: a 31-year perspective. Part III. (1990) (25)
- FK 506 used as rescue therapy for human liver allograft recipients. (1991) (25)
- Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. (1996) (25)
- Acute and chronic rejection in upper extremity transplantation: what have we learned? (2011) (24)
- Detection of pancreatic islet tissue following islet allotransplantation in man. (1991) (24)
- Clonal characteristics of posttransplant lymphoproliferative disorders. (1988) (24)
- Discovery and validation of a novel blood‐based molecular biomarker of rejection following liver transplantation (2020) (24)
- HAMSTER TO RAT KIDNEY XENOTRANSPLANTATION EFFECTS OF FK 506, CYCLOPHOSPHAMIDE, ORGAN PERFUSION, AND COMPLEMENT INHIBITION (1995) (23)
- Histopathology of renal posttransplant lymphoproliferation: comparison with rejection using the Banff schema. (1996) (23)
- Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. (1993) (23)
- 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. (2002) (22)
- Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: Effect of viral hepatitis D (2000) (22)
- Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. (1993) (22)
- Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection. (2020) (22)
- Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. (1992) (22)
- Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. (2000) (22)
- A validated model for predicting outcome after liver transplantation: implications on transplanting the extremely sick (2013) (21)
- Dendritic cell replacement in long-surviving liver and cardiac xenografts. (1993) (21)
- Growth Factor-Induced Mobilization of Dendritic Cells in Kidney and Liver of Rhesus Macaques: Implications for Transplantation (2007) (21)
- IgG4 donor‐specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients (2019) (21)
- Canine total orthotopic small bowel transplantation under FK 506. (1991) (21)
- ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. (1988) (21)
- The pathology of liver transplantation. (1990) (21)
- Hamster coagulation and serum proteins in rat recipients of hamster xenografts. (1993) (20)
- Immune cholangitis: liver allograft rejection and graft-versus-host disease. (1998) (20)
- Recurrent hepatic allograft injury in erythropoietic protoporphyria. (1996) (20)
- Autoimmune liver diseases. Recurrence after liver transplantation. (1999) (20)
- Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. (1996) (20)
- Periportal low-attenuation areas on CT: value as evidence of liver transplant rejection. (1989) (20)
- The two-way paradigm of transplantation immunology. (1996) (20)
- PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease (2018) (20)
- Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis (2018) (19)
- Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. (1993) (19)
- Enhancing the Value of Histopathological Assessment of Allograft Biopsy Monitoring. (2019) (19)
- Memory T Cells Migrate to and Reject Vascularized Cardiac Allografts Independent of the Chemokine Receptor CXCR3 (2011) (19)
- Modulation of Stat3 activation by the cytosolic phospholipase A2α and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway. (2006) (19)
- Extramedullary hematopoiesis in the allograft liver. (1995) (19)
- Peribiliary vascular diseases in rejected livers; computer-aided three-dimensional reconstruction and morphometry. (1991) (19)
- Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells1 (2002) (18)
- The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? (1995) (18)
- Allograft Liver Biopsy in Patients With Epstein-Barr Virus–Associated Posttransplant Lymphoproliferative Disease (2001) (18)
- Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow (1994) (18)
- Analysis of T lymphocytes infiltrating human hepatic allografts. (1987) (18)
- Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients (1990) (18)
- Four-color flow cytometric analysis of peripheral blood donor cell chimerism. (2003) (18)
- Primary carcinoma of stensen's duct: Recognition and management with literature review (1984) (17)
- Frozen section of liver biopsy for the evaluation of liver allografts. (1990) (17)
- EVIDENCE THAT INDEFINITE SURVIVAL OF SMALL BOWEL ALLOGRAFTS ACHIEVED BY A BRIEF COURSE OF CYCLOSPORINE OR FK506 IS NOT DUE TO SYSTEMIC HYPORESPONSIVENESS (1992) (17)
- Long-term survival of heart and liver xenografts with splenectomy and FK 506. (1993) (17)
- Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. (1991) (17)
- SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis (2013) (17)
- Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4+ effector memory T cells (2011) (16)
- Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. (1993) (16)
- Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. (1995) (16)
- Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection. (1990) (16)
- Explanation for loss of the HLA matching effect. (1995) (16)
- Allograft and Xenograft Acceptance under FK‐506 and Other Immunosuppressant Treatment a (1993) (16)
- Recurrent Hepatic Allograft Injury In Erythropoietic Protoporphyria1 (1996) (16)
- DONOR SPECIES COMPLEMENT AFTER LIVER XENOTRANSPLANTATION (1994) (15)
- Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score’s Ability to Determine Long-term Outcome (2017) (15)
- Allograft Outcomes in Outbred Mice (2013) (15)
- Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology. (2012) (15)
- Hepatic antigen-presenting cells and regulation of liver transplant outcome (2011) (15)
- Isolation and primary cultures of human intrahepatic bile ductular epithelium (1988) (15)
- Tacrolimus for rescue of refractory renal allograft rejection. (1998) (15)
- Intrahepatic cholangiographic abnormalities in liver transplants: correlation with biopsy evidence of rejection and other disorders. (1989) (14)
- The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology (2018) (14)
- Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes. (1997) (14)
- Composition of human islet cell preparations for transplantation (2004) (14)
- Human liver xenotransplantation. (1993) (14)
- Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation (2018) (14)
- Medical Progress: Liver Transplantation (2011) (13)
- Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. (1988) (13)
- Cytokine profile in graft-versus-host disease after small bowel transplantation. (1996) (13)
- Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. (1997) (13)
- Memory T cells in GVHD and GVL. (2008) (13)
- Transplantation Pathology of the Liver (2009) (13)
- Renal transplantation at the University of Pittsburgh: the impact of FK506. (1994) (13)
- Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. (1991) (13)
- Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. (2006) (13)
- Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia. (2015) (12)
- Digital pathology services in acute surgical situations (2014) (12)
- Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. (1998) (12)
- Early HCV‐associated stellate cell activation in aggressive recurrent HCV: What can liver allografts teach about HCV pathogenesis? (2005) (12)
- CASE REPORT: Acute Cholestatic Hepatitis Associated with Long-Term Use of Rofecoxib (2004) (12)
- Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. (1998) (12)
- ENHANCEMENT OF THE INDUCTION OF MURINE THYMIC LYMPHOMAS BY CYCLOSPORINE1 (1986) (12)
- Combined bone marrow and whole organ transplantation from the same donor. (1994) (12)
- Clinical intestinal transplantation in 1998: Pittsburgh experience. (1999) (12)
- Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. (1995) (11)
- Bile duct hemorrhage: a biopsy finding after cholangiography or biliary tree manipulation. (2008) (11)
- [113] PROGRESSIVE FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS - ASSOCIATION WITH ALTERED REGENERATION AND A DUCTULAR REACTION (2007) (11)
- Late graft dysfunction after pediatric heart transplantation is associated with fibrosis and microvasculopathy by automated, digital whole-slide analysis. (2017) (11)
- The Histopathological Changes Associated with Allograft Rejection and Drug Toxicity in Renal Transplant Recipients Maintained on FK 506 (2010) (11)
- Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. (1993) (11)
- Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. (1987) (11)
- Human islet allotransplantation in 18 diabetic patients. (1992) (11)
- Heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation. (1996) (11)
- Intrapancreatic islet transplantation as a potential solution to chronic failure of intraportal islet grafts. (1993) (10)
- Control of post-transplant lymphoproliferative disorders and Kaposi's sarcoma by modulation of immunosuppression (1987) (10)
- Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naÏve–-donor-strain bone-marrow cells1 (2003) (10)
- In vitro assessment of FK 506 immunosuppressive activity in transplant patients. (1991) (10)
- Primary cultures of human intrahepatic (biliary) epithelial cells. (1988) (10)
- The Difficulty of Eliminating Donor Leukocyte Microchimerism in Rat Recipients Bearing Established Organ Allografts (2006) (10)
- FK 506 reverses acute graft-versus-host disease following allogeneic bone marrow transplantation in rats (1991) (10)
- Detection of intrahepatic human islets following combined liver-islet allotransplantation. (1992) (10)
- Transforming growth factor-β (TGF-β) activates cytosolic phospholipase A2α (cPLA2α)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated-γ (PPAR-γ)/Smad signaling pathways in human liver cancer cells. A NOVEL MECHANISM FOR SUBVERSION OF TGF-β-INDUCED MITOINHIBITION. (2004) (10)
- Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. (1998) (10)
- Origin of lymph node-derived lymphocytes in human hepatic allografts. (1989) (10)
- 3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury (2006) (10)
- Hereditary Hemorrhagic Telangiectasia of the Liver Complicated by Ischemic Bile Duct Necrosis and Sepsis: Case Report and Review of the Literature (2010) (9)
- Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts (1994) (9)
- The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease. (1994) (9)
- Propagation and characterization of lymphocytes infiltrating livers of patients with primary biliary cirrhosis and autoimmune hepatitis. (1990) (9)
- Spectrum of chronic hepatic allograft rejection and arteriopathy and the controversy of centrilobular necrosis (2000) (9)
- Rejection and hepatitis in liver transplants. (1994) (9)
- Immunopathology of liver transplantation. (1989) (8)
- Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them. (2007) (8)
- Liver allograft pathology in liver/small bowel or multivisceral recipients. (1996) (8)
- Banff consensus recommendations for steatosis assessment in donor livers (2021) (8)
- Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. (1991) (8)
- Hematopoietic reconstitution by transplanted grafts in lethally irradiated recipients. (1997) (8)
- Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. (1988) (8)
- Capillarization of the hepatic sinusoid in failed liver grafts. (1993) (7)
- Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. (1993) (7)
- Clinicopathological Analysis of Uterine Allografts Including Proposed Scoring of Ischemia Reperfusion Injury and T-cell–mediated Rejection—Dallas UtErus Transplant Study: A Pilot Study (2021) (7)
- CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. (2006) (7)
- Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. (1998) (7)
- Prospective evaluation of endoscopy in acute cellular rejection and cytomegalovirus infection. (1996) (7)
- Matching and the black recipient. (1993) (7)
- The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft. (2012) (7)
- CAMPATH PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS (2004) (7)
- Human islet isolation and transplantation in chronic pancreatitis using the automated method. (1992) (7)
- Normotest and abnormal prothrombin in liver transplantation. (2008) (7)
- Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. The Liver Transplantation Database (LTD) Investigators. (1991) (7)
- Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. (1997) (7)
- Pathology of liver transplantation: an update (2000) (7)
- Histologic evaluation of preservation injury in clinical small bowel transplantation. (1994) (7)
- The dichotomous functions of passenger leukocytes in solid-organ transplantation. (1995) (7)
- Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. (1993) (7)
- The effect of splenectomy on cardiac and liver xenografts in the nude rat. (1994) (6)
- Dendritic cells/chimerism/alleviation of chronic allograft rejection (1999) (6)
- Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. (1996) (6)
- NK1.1+ cells promote sustained tissue injury and inflammation after trauma with hemorrhagic shock (2017) (6)
- Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. (1996) (6)
- Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans (2022) (6)
- Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. (1995) (6)
- Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor, native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay. (1994) (6)
- Tacrolimus rescue therapy for renal transplant rejection. (1996) (6)
- 69 – Histological Patterns of Rejection and Other Causes of Liver Dysfunction (2005) (6)
- Longterm outcome of the liver graft: The pathologist's perspective (2017) (6)
- Role of HLA in intragraft cellular immunity in human liver transplantation. (1988) (6)
- Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. (1999) (6)
- Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. (1995) (6)
- Response to Wood and Sachs (1996) (6)
- Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. (1993) (6)
- Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study (2021) (6)
- Biliary Epithelial Cells (2011) (5)
- Results of the initial phase of the portable organ care system (OCS™) liver protect pivotal trial. (2017) (5)
- A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. (2002) (5)
- Intrahepatic bile duct strictures in a liver allograft recipient mimicking recurrent primary sclerosing cholangitis (1991) (5)
- Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. (1993) (5)
- Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. (1994) (5)
- The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. (1993) (5)
- Tacrolimus nephrotoxicity after renal transplantation. (1997) (5)
- Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts (1995) (5)
- Overlap between Alloimmunity and Autoimmunity in the Rat and Human: Evidence for Important Contributions for Dendritic and Regulatory Cells (2003) (5)
- Precision transplant pathology. (2020) (5)
- Comparative analysis of the fate of donor dendritic cells and B cells and their influence on alloreactive T cell responses under tacrolimus immunosuppression. (2005) (5)
- The immunolymphatic theory of chronic rejection. (1997) (5)
- Heterotopic breast epithelial inclusion of the heart: report of a case. (2010) (5)
- HLA matching and the point system. (1993) (5)
- Cellular composition of islet cell suspensions for transplantation. (1992) (5)
- Hepatitis C virus infection in liver allografts. (1995) (5)
- Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. (1994) (5)
- Functional cooperation of xenoproteins after hamster‐to‐rat liver transplantation: With particular reference to hamster C3 and secretory component for rat IgA (1995) (5)
- CHAPTER 32 – Dendritic cells in rejection and acceptance of solid organ allografts (1999) (5)
- Five-year experience with tacrolimus rescue for renal allograft rejection. (1997) (4)
- Mechanisms of protection from humoral rejection by a xenografted liver. (1995) (4)
- Cholestatic jaundice and bone lesions in an elderly woman (2004) (4)
- Expression of Epstein-Barr virus-encoded small RNA by the gene in liver specimens from liver transplant recipients with post-transplant lymphoproliferative disease (1992) (4)
- Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study (2021) (4)
- Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. (1993) (4)
- Dual chamber stent prevents organ malperfusion in a model of donation after cardiac death. (2016) (4)
- Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. (1995) (4)
- FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. (1994) (4)
- Reduction of FK-506 requirements by combination with polyethylene glycol superoxide dismutase in orthotopic rat liver transplantation. (1995) (4)
- Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. (1997) (4)
- Isolated vascular “v” lesions in liver allografts: How to approach this unusual finding (2018) (4)
- Significance of tubulitis in chronic allograft nephropathy: a clinicopathologic study. (1997) (4)
- MIXED CHIMERISM AFTER TRANSPLANTATION: MECHANISM OR MARKER OF SPECIFIC TOLERANCE? (1993) (4)
- Protection from acute cellular injury using Sleeping Beauty mediated telomerase gene transfer. (2007) (4)
- Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. (1996) (4)
- The heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation (Letter) (1996) (3)
- Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice. (1993) (3)
- Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. (2000) (3)
- Biotin-related proteins of 70 and 72 kDa in gallbladder bile in primary biliary cirrhosis (1999) (3)
- Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. (1994) (3)
- CASE REPORT: Suprahepatic Budd-Chiari Syndrome Treated with Thrombectomy and Cavoplasty (2003) (3)
- The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. (1995) (3)
- Subcutaneous implantation of human post‐transplant lymphoproliferative disease lesions in SCID mice (1997) (3)
- The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. (1995) (3)
- Antibody-Mediated Rejection of Human Orthotopic Liver Allografts A Study of Liver Transplantation Across ABO Blood (1988) (3)
- Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies (2022) (3)
- Xenobiotics, chimerism and the induction of tolerance following organ transplantation. (1994) (3)
- Metabolic changes in the recipient after successful liver xenotransplantation in the rat. (1994) (3)
- Inducion of Operational Tolerance By a Cell Therapy Using Donor Ag-Pulsed Tregs in Living Donor Liver Transplantation.: Abstract# 2865 (2014) (3)
- Outcome of human islet isolation and allotransplantation in 20 consecutive cases. (1992) (3)
- Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers (1997) (3)
- Interferon-γ Induced Expression of MHC Antigens Facilitates Identification of Donor Cells in Chimeric Transplant Recipients (1994) (3)
- The enigma of graft acceptance (1995) (3)
- De novo anti-HLA antibodies have the highest incidence in the first year after transplantation (2003) (3)
- Histologic finding of pancreatic islet tissue following intraportal human islet allotransplantation. (1992) (2)
- Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. (1995) (2)
- Cholangiopathy: Genetics, Mechanism, and Pathology (2011) (2)
- Kidney/Bone Marrow Transplantation. (1996) (2)
- Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. (1991) (2)
- GRAFT-VERSUS-HOST DISEASE AFTER BROWN NORWAY-TO-LEWIS AND LEWIS-TO-BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK 506 (2010) (2)
- The Bidirectional Paradigm of Transplant Immunology a (1995) (2)
- Chapter 84 – Histopathology of Liver Transplantation (2015) (2)
- Survival of human hepatocellular aggregates in athymic mice. (1992) (2)
- Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. (1996) (2)
- Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. (1994) (2)
- Combined bone marrow and solid organ transplantation with alemtuzumab induction (2003) (2)
- Delay Allograft Rejection in Lymphopenic Hosts by Downregulating the Homeostatic Proliferation of CD 8 + T Cells (2010) (2)
- Cell migration, chimerism, and graft acceptance: A new view of organ transplantation (1994) (2)
- Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients (2022) (2)
- WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS 1,2 (2010) (2)
- Cell migration, chimerism, and graft acceptance: with particular reference to the liver (2005) (2)
- Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. (1993) (2)
- SUCCESSFUL REVERSAL OF REFRACTORY ACUTE REJECTION WITH CAMPATH 1H IN PANCREAS TRANSPLANTATION RECIPIENTS: 038 (2003) (2)
- An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients (2021) (2)
- A NEW TOLERGENIC IMMUNOSUPPRESSIVE STRATEGY FOR HUMAN INTESTINAL TRANSPLANTATION (2004) (2)
- Rapid Communication S100 Protein Positive Dendritic Cells in Primary Biliary Cirrhosis and Other Chronic Inflammatory Liver Diseases (1989) (2)
- Promotion of Liver Carcinogenesis: Interactions of Barbiturates and a Choline-Deficient Diet (1985) (2)
- Rare Manifestation of Giant Molluscum Contagiosum on the Scalp in Old Age (2013) (2)
- Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. (1996) (2)
- Pathologic Aspects of Hepatocellular Tumors (2009) (2)
- A three-tier Rescue stent improves outcomes over balloon occlusion in a porcine model of noncompressible hemorrhage. (2020) (2)
- A New TCR Transgenic Model of GVHD Reveals That, Independent of Repertoire, Effector Memory T Cells Are Severely Limited, and Central Memory T Cells Somewhat Limited, in Their Ability to Cause GVHD. (2009) (1)
- Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment? (1996) (1)
- The role of the pathology department in a liver transplant program. (1988) (1)
- 688 Identification of human liver myeloid (CD11C+) and lymphoid (CD123+) dendritic cells and their roles in autoimmune liver diseases and liver viral hepatitis (2003) (1)
- Propagation of lymphocytes infiltrating human liver allografts: correlation with histologic diagnosis of rejection (1988) (1)
- IMMUNOMONITORING IN ALLOGRAFT RECIPIENTS TREATED WITH A TOLERANCE-ENHANCING IMMUNOSUPPRESSIVE REGIMEN (2004) (1)
- Intestinal Transplantation for End Stage Crohnʼs Disease: Therapeutic Efficacy and Risk of Recurrence (2006) (1)
- A Comparative Study of Orthotopic Liver Transplant (OLTX) for Sclerosing Cholangitis in Patients With and Without Elevated Serum IgG4 Levels (2011) (1)
- Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. (1999) (1)
- The role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matching. (1993) (1)
- COSTIMULATORY MOLECULE EXPRESSION IN HEART ALLOGRAFTS DEVELOPING CHRONIC REJECTION AND TOLERANCE (1999) (1)
- Indefinite Survival of Rat Islet Allografts following Infusion of Donor Bone Marrow without Cytoablation (1996) (1)
- Neonatal bone fragments for the induction of xenograft acceptance: transplantation of xenogeneic hematopoietic stem cells and species-specific microenvironment for hematopoiesis. (1997) (1)
- Histopathology of Intestinal Transplantation (2009) (1)
- Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice. (1997) (1)
- 566 Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression (2003) (1)
- Clinical xenotransplantation (1994) (1)
- PORTAL VERSUS SYSTEMIC VENOUS DRAINAGE OF INTESTINAL ALLOGRAFTS IN HUMANS (1998) (1)
- ATTENUATION OF CARDIAC ALLOGRAFT VASCULOPATHY BY ADENOVIRAL GENE TRANSFER OF INDUCIBLE NITRIC OXIDE SYNTHASE (1999) (1)
- A Three Tier Rescue Stent Improves Outcomes over Balloon Occlusion in a Porcine Model of Non-Compressible Hemorrhage. (2020) (1)
- disease induction by naive and memory phenotype CD4 T cells Effects of donor T-cell trafficking and priming site on graft-versus-host (2013) (1)
- Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. (1996) (1)
- WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPmNTS1,2 (1995) (1)
- HNF‐Regulated Epithelial Differentiation in Human Liver Diseases (2007) (1)
- Acute liver allograft antibody-mediated rejection (2018) (1)
- Chronic graft injury and long-term outcome after paediatric liver transplantation (2017) (1)
- Use of OKT 3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (2010) (1)
- THYMOGLOBULIN PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS: AN UPDATE (2004) (1)
- Use of FK 506 in the treatment of liver allograft rejection (1991) (1)
- Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. (1995) (1)
- The 65th annual meeting of the american association for the study of liver diseases: the liver meeting 2014. (2014) (1)
- The blind-folding of HLA matching (1993) (1)
- Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. (1994) (1)
- Blood and Biopsy mRNA Expression Signatures Can Distinguish Major Causes of Graft Injury in Liver Transplant Recipients.: Abstract# 2924 (2014) (1)
- T Cells + Homeostatic Proliferation of CD8 Lymphopenic Hosts by Downregulating the NK Cells Delay Allograft Rejection in (2010) (1)
- The BlindFolding of HLA Matching 423 (2010) (1)
- COX‐2‐DERIVED PGE2 ACTIVATES STAT3 THROUGH EP4‐MEDIATED PRODUCTION OF IL‐6 AND EP1‐MEDIATED ACTIVATION OF SRC IN HUMAN CHOLANGIOCARCINOMA CELLS (2006) (1)
- Donor APCs Promote Gvhd in MHC-Mismatched Transplants by Indirectly Presenting Host Minor Histocompatibility Antigens. (2009) (1)
- Prolongation of allograft survival in the BN rat with mercuric chloride autoimmune disease (1994) (1)
- Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease (2014) (0)
- Short Presentations on Posters (2017) (0)
- induction by effector memory T cells A repertoire-independent and cell intrinsic defect in murine GVHD (2013) (0)
- Chronic Liver Allograft Rejection Increased Expression of p 21 WAFlICipl as a Disease Marker and the Influence of Immunosuppressive Drugs (2010) (0)
- Liver , Kidney , and Thoracic Organ Transplantation (2005) (0)
- The pathology of the liver grafts after liver/small bowel or multivisceral transplantation (1995) (0)
- Rapid Communication S1 00 Protein Positive Dendritic Cells in Primary Biliary Cirrhosis and Other Chronic Inflammatory Liver Diseases Relevance to Pathogenesis? (2007) (0)
- Surveillance Biopsies in Pediatric Liver Transplantation: Is the Juice Worth the Squeeze? (2022) (0)
- SF-057-1 Interleukin-6 Protects Ischemia : Reperfusion Injury of Small Bowel Transplant (2004) (0)
- INTESTINAL TRANSPLANTATION.: Abstract# 98 (2000) (0)
- 36 hours of ex-vivo warm cellular perfusion of swine liver using the organ care system (OCS™) liver with excellent functional, metabolic and histological outcomes. (2017) (0)
- CLINICAL FEATURES OF POLYOMA VIRUS INTERSTITIAL NEPHRITIS IN THE ALLOGRAFT KIDNEY. (1998) (0)
- Gender Differences in Estrogen Regulation of Intrahepatic Biliary Epithelial Cell IL‐6 Expression (2009) (0)
- ABDR and amino acid triplet HLA mismatches are associated with the development of anti-HLA antibodies after renal transplantation (2004) (0)
- Chapter 88 – Leukocyte Chimerism—Meaning and Consequences (2015) (0)
- The effect of tertiary lymphoid organs on longterm allograft outcomes and chronic rejection (2010) (0)
- Participation of Cytokines and Growth Factors in Biliary Epithelial Proliferation and Mito-Inhibition during Ductular Reactions (2020) (0)
- 30 Regulation of trefoil factor family expression in biliary epithelial cells by interleukin-6 (IL-6)-mediated GP130 STAT3 signaling under steady state conditions and during biliary tract diseases (2003) (0)
- P149 CROSS-PRESENTATION OF VIRAL ANTIGEN BY LSEC CAN LEAD TO FULMINANT HEPATITIS (2014) (0)
- Expression of NFκB in human liver disease (2001) (0)
- DISTINCT EARLY PATHWAY OF ANTIGEN PRESENTING CELL MIGRATION ASSOCIATED WITH DEVELOPMENT OF CHRONIC ALLOGRAFT REJECTION (1999) (0)
- Concurrent Oral Sessions: Translational (2014) (0)
- Extracellular purines serve as an innate trigger to allograft rejection (145.39) (2010) (0)
- CTLA4Ig REDUCES THE DOSE OF RADIATION REQUIRED TO ACHIEVE MIXED HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC TRANSPLANTATION TOLERANCE IN RATS (1998) (0)
- EFFECTS OF PERITRANSPLANT ADMINISTRATION OF HEMATOPOIETIC GROWTH FACTORS ON THE DEVELOPMENT OF CHRONIC REJECTION (1998) (0)
- Isolation and characterization of a new hepatic epithelial-like cell line (AKN-1) from a normal liver (1998) (0)
- Combined Liver-Islet Allotransplantation (2006) (0)
- Projection from humoral rejection by a xenografted liver (1994) (0)
- Hepatitis viral markers in patients undergoing primary liver transplants (1993) (0)
- Migration of donor MHC class II(+) cells and increase in apoptosis: correlate to graft outcome after heart and liver transplantation. (2001) (0)
- HISTOPAHTOLOGIC CHARACTERISTICS OF HUMAN INTESTINE ALLOGRAFT ACUTE REJECTION IN PATIENTS WITH TOLERIGENIC IMMUNOSUPPRESSION (2004) (0)
- Simultaneous infusion of donor bone marrow at the time of whole organ transplantation (1994) (0)
- The effect of anti-complement agent K76 COOH on hamster and guinea pig to rat heart xenotransplantation (1996) (0)
- Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements. (2023) (0)
- Ischemic cholangitis. (1992) (0)
- Recipient Langerhans Cells Are Neither Required Nor Sufficient for GVHD Induction in MHC-Matched Allogeneic BMT, but a Langerin+ Cell Is a Pivotal Regulator of Langerhans Cell Turnover Post Transplantation (2008) (0)
- TACROLIMUS IS EFFECTIVE AND SAFE FOR RESCUE IN BOTH "LOW RISK" AND "HIGH RISK" PATIENTS (1998) (0)
- History of renal transplantation (1997) (0)
- MIGRATION OF DONOR MHC CLASS II+ CELLS, ACTIVATION OF RECIPIENT IMMUNO RESPONSES, AND APOPTOSIS: COMPARISON BETWEEN HEART AND LIVER TRANSPLANTATION.: Abstract# 1002 (2000) (0)
- Predictors of long-term normal histology on protocol allograft biopsies (2017) (0)
- FK 506, cardiac transplantation, and graft-vessel disease (1992) (0)
- The immunolymphatic theory of chronic rejection : Transplant arteriosclerosis-Chronic rejection (1997) (0)
- DYNAMICS AND CLINICAL SIGNIFICANCE OF ANTI-HLA ALLOANTIBODIES IN SOLID ORGAN TRANSPLANTATION (2004) (0)
- r ' Chronic Liver Allograft Rejection and Obliterative Arteriopathy : Possible Pathogeneic Mechanisms (2010) (0)
- HEAT SHOCK PROTEIN EXPRESSION AND T-CELL REACTIVITY IN RAT CARDIAC ALLOGRAFTS UNDERGOING CHRONIC REJECTION (1998) (0)
- MHC antigen expression on cultured human biliary epithelial cells (1988) (0)
- Role of HLA Class II-Specific Alloreactive T Cells in Biliary Epithelium Injury Associated with Liver Transplant Rejection (1989) (0)
- 771 Prospective and rigorous testing of the ability to distinguish between recurrent hepatitis C and acute and chronic rejection during a tolerance induction trial (2003) (0)
- CYCLOSPORIN, BUT NOT TACROLIMUS, INHIBITS BILIARY EPITHELIAL CELL GROWTH BY STIMULATING TGF&bgr; PRODUCTION.: Abstract# 1091 (2000) (0)
- Pathology of non-rejection complications in liver allografts (1992) (0)
- Whole Blood mRNA to Detect Hepatic Inflammation and Fibrosis in Post-Liver Transplant Patients With HCV.: Abstract# D2356 (2014) (0)
- naive and memory phenotype CD4 T cells Effects of donor T cell trafficking and priming site on GVHD induction by (2008) (0)
- Pathology of the Allograft Pancreas (2006) (0)
- Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor MHC class II+ cells (2002) (0)
- Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15 (2023) (0)
- Acute and Chronic Rejection in Upper Extremity What Have We Learned (2011) (0)
- P609 - Increased incidence of viral hepatitis in HLA compatible liver transplant recipients (1996) (0)
- Use of Alerntuzumab and Tacrolirnus Monotherapy for Cadaveric Liver Transplantation : With Particular Reference to Hepatitis C Virus (2010) (0)
- Oral Abstracts – Liver Session (2004) (0)
- SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis (2013) (0)
- This information is current as Graft-versus-Host Disease Induction and B Cells Does Not Prevent Cells , Dendritic Cells , Plasmacytoid Dendritic Profound Depletion of Host Conventional (2012) (0)
- Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality. (2021) (0)
- Liver allograft pathology in liver/small bowel or multivisceral recipients. (1996) (0)
- PANCREATIC TRANSPLANTATION IN ABDOMINAL VISCERAL RECIPIENTS: INDICATIONS, IMMUNOGENICITY AND FUNCTIONAL OUTCOME (2004) (0)
- CAUSES OF RETRANSPLANTATION, RATE AND SURVIVAL AFTER 4000 CONSECUTIVE PRIMARY LIVER TRANSPLANTATIONS FROM A SINGLE CENTER WITH 15 YEARS MEDIAN FOLLOWUP.: Abstract# 800 Poster Board #‐Session: P57‐III (2000) (0)
- Novel methods for detection of donor cells infiltrating recipient tissue after solid organ transplants (1992) (0)
- Mouse liver allograft rejection correlates with enhanced TH1 function (1994) (0)
- Tacrolimus ( FK 506 ) and the Pharmaceuticall Academid Regulatory Gauntlet (2010) (0)
- Mucosal recipient‐type mononuclear repopulation and low‐grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts (1994) (0)
- Hepatic artery (HA) vasospasm in the small-for-size liver graft syndrome (SFSS) is independent of norepinephrine (NE) (2008) (0)
- mTOR and Vascular Biology: Discovery to Translation (2008) (0)
- High Mobility Group B1 Matures Dendritic Cells and is A DAMP Elevated in the Serum of Hepatoma Patients With Chronic Hepatitis C Diminishing Following Resection and Orthotopic Liver Transplantation or Radiofrequency Ablation [RFA] (2005) (0)
- Recent Advances in Hepatic Transplantation at (1993) (0)
- tolerance following organ transplantation (1994) (0)
- Special Emphasis onAnalysis ofDuctular Hepatocytes (1996) (0)
- Pro-Inflammatory Cytokine Modulation of the IL-33 Receptor During Pediatric Allograft Rejection.: Abstract# A24 (2014) (0)
- Pseudotumor of pancreas with biliary sclerosis (2003) (0)
- Machine perfusion under subnormothermic conditions with a new oxygen-carrier solution (2012) (0)
- 10.1-02 Propagation and characterization of lymphocytes infiltrating livers of patients with hepatic autoimmune diseases (1989) (0)
- (346) – Late Graft Dysfunction After Pediatric Heart Transplantation Is Associated with Fibrosis and Decreased Capillary Density by Automated, Whole-Slide Imaging (2017) (0)
- THE PATHOPHYSIOLOGY ASSOCIATED WITH SMALL-FOR-SIZE LIVER GRAFTS (2004) (0)
- Non-MHC restriction in the protection from humoral rejection given by a hepatic xenograft (1994) (0)
- PD-L1 and PD-L2 Protect The Heart In a T-Cell Receptor Transgenic Model Of Graft-Versus Host Disease (2013) (0)
- The Pittsburgh Upper Extremity Transplant Program - Early and Emerging Outcomes in Five Recipients with a Novel Immunomodulatory Protocol: 2309 (2012) (0)
- - ) ng-Term Survival of Heart and Liver Xenografts With Splenectomy (0)
- POSTTRANSPLANT LYMPHOROLIFERATIVE DISORDERS (PTLD) IN INTESTINAL TRANSPLANT RECIPIENTS (2004) (0)
- 34-P: Clinical and Pathological Significance of Anti-Donor Antibodies in Liver Allograft Recipients (2010) (0)
- S-I-6 Histologic Diagnosis of Liver Transplant Rejecton (1992) (0)
- Two-Way Paradigm ( Organ ) \ " , " , unosuppression GVH Mutual Natural Immunosuppression (0)
- Contributions for Dendritic and Regulatory Cells Overlap between Alloimmunity and Autoimmunity in the Rat and Human : Evidence for Important (2003) (0)
- Wound healing in the biliary tree of liver allografts. (2006) (0)
- Structural Clustering With Clinical Correlates in Stable Long-Term Pediatric Liver Transplant Recipients With Normal Liver Tests: A Prospective Multi-Center Study.: Abstract# 1402 (2014) (0)
- 29 New onset of autoantibodies and hepatic disease in liver transplanted children (2003) (0)
- EFFECT OF FLT-3 LIGAND ON ALLOGENEIC CHIMERISM AFTER ORGAN TRANSPLANTATION: LYMPHOID AND NONLYMPHOID COMPARTMENTATION OF CHIMERISM (1998) (0)
- CHRONIC REJECTION OF THE INTESTINAL ALLOGRAFT.: Abstract# 203 Poster Board #‐Session: P50‐I (2000) (0)
- Epstein-Barr virus-encoded RNA expression as a risk factor for the development of posttransplantation lymphoproliferative disease. (1995) (0)
- Redundant Mechanisms for Dendritic Cell Activation in GVHD Induction: Signalings Via TLRs, TNF-α, IL-1 and CD40 Are Not Required (2008) (0)
- Incidence and Severity of Acute Allograft Rejection in Liver Transplant Recipients Treated With Alfa lnterferon (2010) (0)
- 112Causes of retransplantation FTER 4000 consecutive primary liver transplantations from a single center with 15 years median followup rate and survival (2000) (0)
- 69 Pathology of Liver Transplantation (2010) (0)
- Correspondence (1995) (0)
- IgG lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance (1995) (0)
- A Validated Model for Predicting Outcome after Liver Transplantation: Implications on Transplanting the Extremely Sick: 2441 (2012) (0)
- INTESTINAL TRANSPLANTATION AND BONE MARROW AUGMENTATION.: Abstract# 754 Poster Board #‐Session: P11‐III (2000) (0)
- ABDOMINAL MULTIVISCERAL TRANSPLANTATION1,2 (2010) (0)
- Ultrasound-Targeted Microbubble Cavitation During Machine Perfusion Reduces Microvascular Thrombi and Graft Injury in a Rat Liver Model of Donation After Circulatory Death. (2023) (0)
- UTILIZATION OF LIVERS FROM CONTROLLED NON-HEARTBEATING DONORS (NHBD)- A SINGLE CENTER EXPERIENCE ON 55 LIVER TRANSPLANTS OVER A 10-YEAR PERIOD (2004) (0)
- FORSKOLIN PREVENTS ISCHEMIA/REPERFUSION INJURY AFTER SMALL INTESTINAL TRANSPLANTATION IN RATS (2004) (0)
- Production a IL-15/IL-15RIschemia/Reperfusion Injury via Hepatocyte IRF-1 Promotes Liver Transplant (2015) (0)
- Reprinted from transplantation (2010) (0)
- Authors' Reply: Post-transplant Livers (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anthony-jake Demetris?
Anthony-jake Demetris is affiliated with the following schools:
